CSIMarket Company Name, Ticker, Suppliers, else..
 
Sanara Medtech Inc   (SMTI)
Other Ticker:  
 
 
Price: $34.4800 $-0.20 -0.577%
Day's High: $35 Week Perf: -1.51 %
Day's Low: $ 33.17 30 Day Perf: 5.38 %
Volume (M): 30 52 Wk High: $ 43.25
Volume (M$): $ 1,021 52 Wk Avg: $33.06
Open: $34.22 52 Wk Low: $26.00



 Market Capitalization (Millions $) 290
 Shares Outstanding (Millions) 8
 Employees -
 Revenues (TTM) (Millions $) 66
 Net Income (TTM) (Millions $) -5
 Cash Flow (TTM) (Millions $) -4
 Capital Exp. (TTM) (Millions $) 0

Sanara Medtech Inc
Sanara Medtech Inc is a medical technology company focused on developing and commercializing innovative products to improve wound care. They specialize in advanced wound care products, including dressings and devices that promote accelerated healing and reduce the risk of infection. Sanara Medtech's products are designed to be easy to use and provide effective solutions for clinicians and patients. The company aims to improve patient outcomes and enhance the quality of life for individuals suffering from chronic and acute wounds.


   Company Address: 1200 Summit Ave Fort Worth 76102 TX
   Company Phone Number: 529-2300   Stock Exchange / Ticker: NASDAQ SMTI


   

Stock Performances by Major Competitors

5 Days Decrease / Increase
     
• View Complete Report
   



Sanara Medtech Inc

Sanara Medtech Inc Reports Strong Revenue Growth but Fails to Achieve Profitability in Q1 2024



Sanara Medtech Inc, a medical equipment and supplies company, witnessed a significant increase in revenue for the financial period ending March 31, 2024. Despite this positive trajectory, the company reported a widening deficit per share. Additionally, Sanara Medtech Inc's stock experienced a decline during May 2024, and it currently trades relatively close to its 52-week low.
Revenue Growth and Deficit Per Share:
Sanara Medtech Inc generated $17.65 million in revenue for the financial period ending March 31, 2024. This represents a noteworthy increase of 13.688% compared to the corresponding reporting period a year prior. However, the company experienced a deficit per share of $-0.21, signaling a deterioration in its financial performance.
Sanara Medtech Inc

Sanara Medtech Inc reports strong revenue growth but falls short of profitability in fiscal fourth quarter of 2023

Financial News Report: Sanara Medtech Inc Reports Improved EPS and Revenue Growth
Sanara Medtech Inc, a leading company in the Medical Equipment & Supplies industry, has released its financial results for the fiscal span ending December 31, 2023. The company's performance showcases positive developments in both earnings per share (EPS) and revenue growth.
For the fiscal span ending December 31, 2023, Sanara Medtech Inc reported an EPS of $-0.03 per share, reflecting an increase from $-0.01 per share in the previous year. Furthermore, the company displayed improved EPS compared to the preceding reporting season where it reported $-0.13 per share.
Sanara Medtech Inc

Vanishing Deficit at SMTI over the July to September 30 2023 fiscal interval



Sanara Medtech Inc, a medical equipment and supplies company, has recently witnessed a decline in its share performance and reported its financial results for the third quarter of 2023. This article aims to interpret these results and speculate on the potential impact they may have on the company's future.
1. Share Performance:
Over the past seven days, Sanara Medtech Inc shares experienced a drop of -0.85%, bringing the year-to-date performance to -18.99%. Furthermore, the shares are trading only 25.9% above their 52-week low. These figures suggest a concerning trend for shareholders and indicate a lack of market confidence in the company's prospects.
Sanara Medtech Inc

Sanara Medtech Inc's Surprising Second Quarter Earnings Report: Analyzing the Impact on Future Performance



Sanara Medtech Inc, a leading player in the Medical Equipment & Supplies industry, has recently released its financial results for the second quarter of 2023 earnings season. This article aims to interpret the implications of these results and their potential impact on the company's future performance.
1. Declining Stock Performance:
Over the last five trading days, Sanara Medtech Inc's stock experienced a significant drop of -12.09%. Furthermore, the year-to-date performance stands at -1.95%. Investors might be concerned by these downward trends, prompting a closer look into the factors driving this decline.
Sanara Medtech Inc

Sanara Medtech Inc Reports Impressive Revenue Increase in Q1 2023 Despite Slight Losses

Sanara Medtech Inc is a healthcare company that designs and manufactures advanced wound care and regenerative medicine products. The company has been in operation for several years, and despite some challenges, it has shown remarkable growth and resilience, particularly in the past quarter.
The company recently reported its financial results for the first quarter ending on March 31, 2023. In the quarter, the company reported a loss of $-0.14 per share, compared to a loss of $-0.41 per share in the same quarter the previous year. Although the loss increased from $-0.01 in the preceding quarter, the company managed to significantly reduce its losses from the previous year.






Sanara Medtech Inc's Segments





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com